Jean Noll, MD
Ophthalmology · Crestview Hills, KYNPI 1760484935
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.2% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations.
Across 195 payments — averaging $27.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$778
- Johnson & Johnson Surgical Vision, Inc.$706
- Alcon$671
- Carl Zeiss Meditec USA, Inc.$454
- Rxsight Inc$353
- Sun Pharmaceutical Industries Inc.$313
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,89290%
- Education$801%
- Other$4548%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $778 |
| Johnson & Johnson Surgical Vision, Inc. | 28 | $706 |
| Alcon | 19 | $671 |
| Carl Zeiss Meditec USA, Inc. | 1 | $454 |
| Rxsight Inc | 8 | $353 |
| Sun Pharmaceutical Industries Inc. | 13 | $313 |
| Ocular Therapeutix, Inc. | 3 | $224 |
| Bausch & Lomb Americas Inc. | 10 | $213 |
| Harrow Eye, LLC | 5 | $210 |
| Tarsus Pharmaceuticals, Inc. | 7 | $179 |
| Amgen(2 entities) | 10 | $176 |
| Rayner Intraocular Lenses Limited | 7 | $130 |
| Omeros Corporation | 7 | $117 |
| Dompe US, Inc. | 1 | $112 |
| Lensar, Inc. | 1 | $104 |
| Mallinckrodt Hospital Products Inc. | 4 | $94 |
| Novartis | 5 | $74 |
| Shire North American Group Inc | 4 | $66 |
| Sight Sciences, Inc. | 3 | $57 |
| Oyster Point Pharma, Inc. | 3 | $55 |
| Biotissue Holdings Inc. | 1 | $47 |
| Aerie Pharmaceuticals, Inc. | 3 | $46 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $38 |
| Lombart Brothers, Inc. | 2 | $27 |
| Alimera Sciences, Inc. | 1 | $26 |
| Glaukos Corporation | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Eyevance Pharmaceuticals LLC | 1 | $19 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
| Lumibird Medical Inc. | 1 | $17 |
| NEW World Medical,inc. | 1 | $15 |
| Halozyme Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CIRRUS 5000 with AngioPlex$454
- RXSIGHT CONTACT LENS$245
- RXSIGHT INJECTOR CARTRIDGE$245
- RXSIGHT INJECTOR HANDPIECE$245
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$245
- VEVYE$150
- Hydrus Microstent$150
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$141
- DEXTENZA$121
- Oxervate$112
- DURYSTA$104
- LENSAR LASER SYSTEM$104
- LIGHT ADJUSTABLE LENS (LAL)$103
- CEQUA$103
How this compares
$5,426 in reported general payments places this provider in the 85th percentile of 216 ophthalmology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 144 | $214,812 |
| Cyclosporine | 32 | $37,177 |
| CombiganBrimonidine Tartrate/Timolol | 45 | $19,012 |
| RocklatanNetarsudil Mesylat/Latanoprost | 37 | $17,832 |
| Alphagan PBrimonidine Tartrate | 41 | $14,994 |
| LumiganBimatoprost | 27 | $9,858 |
| Fluorometholone | 54 | $5,541 |
| Latanoprost | 576 | $5,414 |
| Cosopt PfDorzolamide/Timolol/Pf | 12 | $2,460 |
| Prednisolone Acetate | 40 | $2,180 |
| Brimonidine Tartrate | 119 | $2,176 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 117 | $2,117 |
| Timolol Maleate | 150 | $1,214 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $1,178 |
| Dorzolamide Hcl | 40 | $675 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Combigan, Alphagan P, Lumigan | $778 | $258,677257 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $46 | $17,83237 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 216 ophthalmology providers in Kentucky.
Other ophthalmology in Crestview Hills
- Saif JaweedCrestview Hills$12K
- Aaron NollCrestview Hills$9K
- Matthew DykhuizenCrestview Hills$4K
- Edward HollandEdgewood$678K
- Gary WortzLexington$159K
- Jeremy ClarkLouisville$131K
- Bruce KofflerLexington$49K
- Guruprasad PattarLouisville$36K
- Jeffery TaylorPaducah$18K
- Asim PirachaLexington$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.